Evaxion Biotech As Stock Market Value
| EVAX Stock | USD 3.34 0.15 4.70% |
| Symbol | Evaxion |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evaxion Biotech. Projected growth potential of Evaxion fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Evaxion Biotech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.00) | Revenue Per Share | Quarterly Revenue Growth 1.483 | Return On Assets | Return On Equity |
The market value of Evaxion Biotech AS is measured differently than its book value, which is the value of Evaxion that is recorded on the company's balance sheet. Investors also form their own opinion of Evaxion Biotech's value that differs from its market value or its book value, called intrinsic value, which is Evaxion Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evaxion Biotech's market value can be influenced by many factors that don't directly affect Evaxion Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Evaxion Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evaxion Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Evaxion Biotech's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Evaxion Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evaxion Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evaxion Biotech.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Evaxion Biotech on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Evaxion Biotech AS or generate 0.0% return on investment in Evaxion Biotech over 90 days. Evaxion Biotech is related to or competes with Reviva Pharmaceuticals, Annovis Bio, PolyPid, Generation Bio, Bioatla, Veru, and SAB Biotherapeutics. Evaxion Biotech AS, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherap... More
Evaxion Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evaxion Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evaxion Biotech AS upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 37.88 | |||
| Value At Risk | (8.42) | |||
| Potential Upside | 9.15 |
Evaxion Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evaxion Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evaxion Biotech's standard deviation. In reality, there are many statistical measures that can use Evaxion Biotech historical prices to predict the future Evaxion Biotech's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.85) | |||
| Total Risk Alpha | (1.26) | |||
| Treynor Ratio | (1.19) |
Evaxion Biotech February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | (1.18) | |||
| Mean Deviation | 4.51 | |||
| Coefficient Of Variation | (752.71) | |||
| Standard Deviation | 6.01 | |||
| Variance | 36.14 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.85) | |||
| Total Risk Alpha | (1.26) | |||
| Treynor Ratio | (1.19) | |||
| Maximum Drawdown | 37.88 | |||
| Value At Risk | (8.42) | |||
| Potential Upside | 9.15 | |||
| Skewness | 0.513 | |||
| Kurtosis | 2.14 |
Evaxion Biotech AS Backtested Returns
Evaxion Biotech AS secures Sharpe Ratio (or Efficiency) of -0.0873, which denotes the company had a -0.0873 % return per unit of standard deviation over the last 3 months. Evaxion Biotech AS exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Evaxion Biotech's Coefficient Of Variation of (752.71), mean deviation of 4.51, and Standard Deviation of 6.01 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.68, which means possible diversification benefits within a given portfolio. As returns on the market increase, Evaxion Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Evaxion Biotech is expected to be smaller as well. At this point, Evaxion Biotech AS has a negative expected return of -0.53%. Please make sure to confirm Evaxion Biotech's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Evaxion Biotech AS performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.03 |
Very weak reverse predictability
Evaxion Biotech AS has very weak reverse predictability. Overlapping area represents the amount of predictability between Evaxion Biotech time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evaxion Biotech AS price movement. The serial correlation of -0.03 indicates that only 3.0% of current Evaxion Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.03 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.63 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.